Based on recent data, Opus Genetics, Inc. (IRD) shows an Average True Range (ATR) of 0.25 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 912.74K, indicating liquidity. These fundamental metrics provide insight into IRD's underlying financial health and market activity.
| ATR | 0.25 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 912.74K |
| Avg Vol (10 Days) | 703.89K |
Opus Genetics, Inc. (IRD) technical indicators as of March 26, 2026: the SMA 20 is 13.28%, SMA 50 at 39.51%, and SMA 200 at 106.75%. The RSI 14 value is 62.44, suggesting its current momentum. These technical analysis signals help assess IRD's price trends and potential future movements.
| SMA 20 | 13.28% |
| SMA 50 | 39.51% |
| SMA 200 | 106.75% |
| RSI 14 | 62.44 |
Opus Genetics, Inc. (IRD) stock performance overview as of March 26, 2026: The 52-week high is $5.3 (currently -9.46% below), and the 52-week low is $0.65 (currently 452.31% above). Over the past year, IRD's performance is 94.83%, compared to the S&P 500's 14.34% change.
| 52-Week High | 5.3 |
| 52-Week High Chg | -9.46% |
| 52-Week Low | 0.65 |
| 52-Week Low Chg | +452.31% |
| S&P 500 52-Week Chg | 14.34% |
According to market data, Opus Genetics, Inc. (IRD) stock's recent performance metrics show that over the last month, IRD is 11.88%, with a Year-to-Date (YTD) performance of 12.44%. Over the past year, the stock has seen a 94.83% change. These figures summarize IRD's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.79 | 5.3 | 5.3 | 5.3 | 5.3 | 5.3 |
| Low | 4.32 | 3.29 | 1.88 | 1.42 | 0.65 | 1.88 |
| Performance | +10.24% | +11.88% | +20.86% | +89.92% | +94.83% | +12.44% |
According to current financial data, IRD stock's P/E (TTM) ratio is -58.25, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for IRD, including P/S (23.27), P/B (188.21), and P/FCF (-9.37), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | IRD | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -58.25 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 23.27 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 188.21 | 7.62 | 4.77 | 4.62 |
| P/FCF (TTM) | -9.37 | 72.79 | -221.03 | 32.15 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep